SLAMF1 and B-cell chronic lymphocytic leukemia: An empirical investigation indicated that loss of SLAMF1 expression in CLL alters genetic pathways that orchestrate chemotaxis and autophagy and treatment responses, raising the possibility that these alterations are responsible for the worse clinical outcomes observed by patients with SLAMF1 low expression (11).